Press release
Dengue Vaccine Market Set to Soar: Innovations, Demand Surge, and Growth Opportunities 2026-2034 | Major Companies - Sanofi, Panacea Biotec, Biological, GlaxoSmithKline plc
Dengue Vaccine Market
The Dengue Vaccine Market is expected to grow at a CAGR of 10.4% during the forecast period 2024-2031.
The Dengue Vaccine Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/dengue-vaccine-market?sz
The Dengue Vaccine Market encompasses the development, production, and commercialization of vaccines designed to prevent dengue virus infections transmitted by Aedes mosquitoes. It includes vaccines for all age groups, targeting regions with high dengue prevalence. Market growth is driven by rising dengue cases, government immunization programs, technological advancements in vaccine formulations, and increasing awareness of vector-borne disease prevention.
Recent Key Developments of United States:
✅ December: Sanofi announced discontinuation of Dengvaxia production effective September 2025 due to low demand, with shelf life extending to September 2026.
✅ November: Merck updated its product pipeline, highlighting V181 as an investigational quadrivalent dengue vaccine in active clinical development.
✅ October: Merck's V181 dengue vaccine study advanced with ongoing enrollment in a trial evaluating safety and immunogenicity in healthy participants aged 2 and older.
Recent Key Developments of Europe:
✅ December: A self-reported study (Feb 2023-Feb 2025) confirmed the tolerability of Takeda's Qdenga (TAK-003) in German travelers, supporting its use from age 4 regardless of prior exposure.
✅ November: EMA pledged support for dengue prevention studies and mosquito control, incorporating vaccination into public health plans in countries like France and Spain.
✅ October: The European Commission withdrew marketing authorization for Sanofi's Dengvaxia on October 21 at the company's request for commercial reasons.
List of the Key Players in the Dengue Vaccine Market:
Sanofi
Panacea Biotec
Biological
E. Limited
GlaxoSmithKline plc
Merck & Co.
Takeda Pharmaceutical Company Ltd
Vabiotec
Panacea Biotec
Medigen Biologics.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/dengue-vaccine-market?sz
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the Dengue Vaccine Market:
By Type: CYD-TDV, DENVax or TAK-003, TetraVax-DV, TDENV PIV, V180.
By End-user: Hospitals, Clinics, Vaccination Center, Others.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=dengue-vaccine-market
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Dengue Vaccine market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Dengue Vaccine Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global Dengue Vaccine market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Dengue Vaccine Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Dengue Vaccine Market in 2025?
◆ What is the projected growth rate of the Dengue Vaccine Market through 2033?
◆ Who are the key players in the Dengue Vaccine Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dengue Vaccine Market Set to Soar: Innovations, Demand Surge, and Growth Opportunities 2026-2034 | Major Companies - Sanofi, Panacea Biotec, Biological, GlaxoSmithKline plc here
News-ID: 4333861 • Views: …
More Releases from DataM Intelligence 4Market Research
Angiography Devices Market is expected to reach US$ 20.74 Billion by 2033 | Top …
Market Size and Growth:
The Global Angiography Devices Market size was US$ 12.94 Billion in 2024 and is expected to reach US$ 20.74 Billion by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033.
The Angiography Devices Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
Antidepressant Drugs Market is expected to reach US$ 20.6 billion by 2031 | Majo …
Market Size and Growth:
The Global Antidepressant Drugs Market size reached US$ 14.3 billion in 2022 and is expected to reach US$ 20.6 billion by 2031, growing with a CAGR of 5.56% during the forecast period 2024-2031.
The Antidepressant Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
Hunter Syndrome Treatment Market is expected to reach US$ 1,417.79million by 203 …
Market Size and Growth:
The Global Hunter Syndrome Treatment Market size reached US$ 747.06 million in 2024 and is expected to reach US$ 1,417.79million by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
The Hunter Syndrome Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make…
Force Sensors Market Accelerates as Automation, Robotics, and Smart Manufacturin …
Market Overview:
The Global Force Sensors Market is estimated to reach at a CAGR of 6.96% during the forecast period 2024-2031.
The Force Sensors Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods,…
More Releases for Dengue
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240
The report provides a comprehensive analysis of company profiles listed below:
- Sanofi
- Takeda
Dengue Vaccines Market Segment by…
